The skin is the largest organ in the body with remarkable physiological and social functions. The epidermal portion of the skin is responsible for waterproofing the body and acting as a mechanical barrier; thus, it is associated with vital functions. Upon injury, the immediate response of the epidermis and its stem cells aims at the reestablishment of local homeostasis; however extensive injuries, often observed in burn patients, may overwhelm the capacity to heal. If the epidermis-driven homeostasis is not restored, the organism undergoes dehydration and increased chances for infection and death. New therapeutic strategies aiming at accelerated epithelial migration and accumulation of epithelial stem cells are in great need to improve the health of burn patients and the achievement of better clinical outcomes. Our research bridges new findings in the field of stem cell biology with recent understanding of the role of the phosphatidylinositide 3-kinases (PI3K) molecular mechanisms in response to epithelial injury. PTEN was initially identified as a negative regulator of the PI3K signaling, the main regulator of cell growth, metabolism, and survival. By targeted disrupting the PTEN gene from the epithelial layer of the skin containing stem cells, we observed a brisk activation of cellular proliferation associated with increased migration. Moreover, we found that disruption of PTEN from the epidermis also results in the accumulation of epithelial stem cells indicating a critical role of the PI3K signaling pathway in the maintenance of epithelial homeostasis and response to external injuries. Here, we propose a novel therapeutic strategy to treat wounds by increasing the population of skin stem cells at the donor site before the isolation and graft in the injured recipient site. Furthermore, we will determine the therapeutic effectiveness of pharmacological action on the PI3K signaling during the re-epithelization and scarring after burn. Human- relevant preclinical animal models will be used to test our hypothesis on the efficacy of the PI3K in the treatment of burn. This application is significant; once that will explore novel druggable pathways capable of accelerating epithelial migration and wound closure, induce accumulation of epidermal stem cells, and reduce the development of wound scar.

Public Health Relevance

Burns a r e a global health problem that affect more than 1 million individuals annually and are the seventh leading cause of injury death in the US. Fires and burns are the third leading cause of fatal home injury. Following burns and surgery, healing is slow and up to 90% of patients develop scars, which are difficult to treat and affect the patient's physical and psychological quality of life. Our research focuses on developing new therapies to treat burns and scarring.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM120056-02
Application #
9511897
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Somers, Scott D
Project Start
2017-06-19
Project End
2022-04-30
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Dentistry
Type
Schools of Dentistry/Oral Hygn
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109